Artificial intelligence is supercharging CRISPR genome editing, making it faster, more precise, and safer. From designing optimal guide RNAs to predicting and preventing off-target effects, AI tools ...

The gene editing treatment targets the relatively common 1717-1G>A splicing mutation, which does not respond to many current CF therapies.

Charles Gersbach and his colleagues are pursuing promising CRISPR technologies focused on controlling gene activity rather ...

A platform approach to gene editing brings together design, manufacturing, validation, analytics, and regulatory considerations right from the start.

NIH-funded UT team and colleagues from Metagenomi Thereapeutics discovered highly efficient enzyme could enable targeted gene editing within the human body.

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death globally, with incidence continuing to rise in many regions. Despite advances in ...

A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.

A growing body of research shows that cultural values strongly influence public attitudes toward CRISPR, with Japanese respondents focusing on legal frameworks and Americans on religious concerns.

Waking up this morning to news of the much-deserved Nobel Prize win for Emmanuelle Charpentier and Jennifer A. Doudna "for the development of a method for genome editing" confirms the importance of ...